| Optimal medical therapy with or without PCI for stable coronary disease WE Boden, RA O'Rourke, KK Teo, PM Hartigan, DJ Maron, WJ Kostuk, ... New England journal of medicine 356 (15), 1503-1516, 2007 | 5832 | 2007 |
| Initial invasive or conservative strategy for stable coronary disease DJ Maron, JS Hochman, HR Reynolds, S Bangalore, SM O’Brien, ... New England Journal of Medicine 382 (15), 1395-1407, 2020 | 2288 | 2020 |
| Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and … LJ Shaw, DS Berman, DJ Maron, GBJ Mancini, SW Hayes, PM Hartigan, ... Circulation 117 (10), 1283-1291, 2008 | 2004 | 2008 |
| Current perspectives on statins DJ Maron, S Fazio, MRF Linton Circulation 101 (2), 207-213, 2000 | 1819 | 2000 |
| Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary … WL Haskell, EL Alderman, JM Fair, DJ Maron, SF Mackey, HR Superko, ... Circulation 89 (3), 975-990, 1994 | 1272 | 1994 |
| Effect of PCI on quality of life in patients with stable coronary disease WS Weintraub, JA Spertus, P Kolm, DJ Maron, Z Zhang, C Jurkovitz, ... New England Journal of Medicine 359 (7), 677-687, 2008 | 924 | 2008 |
| ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American … MR Patel, JH Calhoon, GJ Dehmer, JA Grantham, TM Maddox, DJ Maron, ... Journal of the American College of Cardiology 69 (17), 2212-2241, 2017 | 681 | 2017 |
| Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI … WE Boden, RA O’rourke, KK Teo, PM Hartigan, DJ Maron, WJ Kostuk, ... N Engl J Med 356 (15), 1503-16, 2007 | 511 | 2007 |
| Postexercise nutrient intake timing in humans is critical to recovery of leg glucose and protein homeostasis DK Levenhagen, JD Gresham, MG Carlson, DJ Maron, MJ Borel, ... American Journal of Physiology-Endocrinology and Metabolism, 2001 | 476 | 2001 |
| Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial DJ Maron, GP Lu, NS Cai, ZG Wu, YH Li, H Chen, JQ Zhu, XJ Jin, ... Archives of internal medicine 163 (12), 1448-1453, 2003 | 458 | 2003 |
| Health-status outcomes with invasive or conservative care in coronary disease JA Spertus, PG Jones, DJ Maron, SM O’Brien, HR Reynolds, ... New England Journal of Medicine 382 (15), 1408-1419, 2020 | 453 | 2020 |
| Management of coronary disease in patients with advanced kidney disease S Bangalore, DJ Maron, SM O’Brien, JL Fleg, EI Kretov, C Briguori, U Kaul, ... New England Journal of Medicine 382 (17), 1608-1618, 2020 | 449 | 2020 |
| Psychosocial predictors of physical activity in adolescents KD Reynolds, JD Killen, SW Bryson, DJ Maron, CB Taylor, N Maccoby, ... Preventive medicine 19 (5), 541-551, 1990 | 416 | 1990 |
| Effect of PCI on long-term survival in patients with stable ischemic heart disease SP Sedlis, PM Hartigan, KK Teo, DJ Maron, JA Spertus, GBJ Mancini, ... New England Journal of Medicine 373 (20), 1937-1946, 2015 | 374 | 2015 |
| Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optimal medical therapy with or without pci for stable coronary disease WE Boden, RA O’Rourke, KK Teo, PM Hartigan, DJ Maron, WJ Kostuk, ... N Engl J Med 356 (15), 1503-1516, 2007 | 365 | 2007 |
| Results of the national cholesterol education (NCEP) program evaluation project utilizing novel E-technology (NEPTUNE) II survey and implications for treatment under the recent … MH Davidson, KC Maki, TA Pearson, RC Pasternak, PC Deedwania, ... The American journal of cardiology 96 (4), 556-563, 2005 | 332 | 2005 |
| Association of statin adherence with mortality in patients with atherosclerotic cardiovascular disease F Rodriguez, DJ Maron, JW Knowles, SS Virani, S Lin, PA Heidenreich JAMA cardiology 4 (3), 206-213, 2019 | 313 | 2019 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 289 | 2019 |
| International study of comparative health effectiveness with medical and invasive approaches (ISCHEMIA) trial: rationale and design DJ Maron, JS Hochman, SM O’Brien, HR Reynolds, WE Boden, ... American heart journal 201, 124-135, 2018 | 269 | 2018 |
| Postexercise protein intake enhances whole-body and leg protein accretion in humans DK Levenhagen, C Carr, MG Carlson, DJ Maron, MJ Borel, PJ Flakoll Medicine & Science in Sports & Exercise 34 (5), 828-837, 2002 | 253 | 2002 |
